Comment by pkaye

But this seems to be different situation from what the article is talking about which is the inadequate involvement of minorities in drug trials. You are highlighting the lack of adequate health coverage which is a different issue in the US. But this bring up a question if blacks and other minorities have the poorer health outcomes in other countries? Japan, China, South Korea for example does their own drug testing and development so would they find that a particular drug doesn't work on their population at all? What about the black population in UK or France? Do they also have poorer health outcomes?